Postmortem mu-opioid receptor binding in suicide victims and controls
1Division of Neuroscience, Department of Psychiatry, Columbia University, New York, NY 10032, USA.
Summary
This study found no difference in mu-opioid receptor binding between suicide victims and controls. However, binding affinity varied by brain region in suicide victims, suggesting altered opiate transmission.
Area of Science:
- Neuroscience
- Neurochemistry
- Psychiatry
Background:
- Endogenous opiates may reinforce self-injurious behavior.
- Previous studies suggest higher mu-opioid receptor binding in some brain regions of young suicide victims.
- This study investigated opioid receptor binding kinetics in postmortem brains.
Purpose of the Study:
- To compare mu-opioid receptor binding kinetics in postmortem brains of young suicide victims and matched controls.
- To examine receptor density (Bmax) and affinity (K(D)) in specific brain regions.
Main Methods:
- Postmortem brain tissue from 9 suicide victims and 10 controls were analyzed.
- Mu-opioid receptor binding kinetics were measured using [3H] DAGO.
- Analyses focused on the prefrontal cortex (PFC) and pre-post central gyri (PPCG).
Main Results:
- No significant differences in mu-opioid receptor binding indices were found between suicide victims and controls.
- Prefrontal cortex (PFC) showed higher mu-opioid receptor density (Bmax) than pre-post central gyri (PPCG).
- A significant interaction between binding affinity (K(D)) and group was observed, with differences in PFC and PPCG between victims and controls.
Conclusions:
- Mu-opioid receptors are more abundant in the PFC compared to PPCG, irrespective of suicide status.
- Region-specific differences in binding affinity in suicide victims suggest altered regional opiate transmission.
- Findings highlight potential neurobiological differences in brain regions related to suicide.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...